HPVs |
Human papillomaviruses |
CEC |
cervical cancer |
OPC |
oropharyngeal cancer |
ct-DNA |
Circulating tumor DNA |
PCR |
polymerase chain reaction |
ddPCR |
digital droplet-based PCR |
HR |
high-risk |
ISH |
in situ hybridization |
TA-4 |
tumor associated antigen 4 (the squamous cell carcinoma antigen) |
CEA |
Carcino Embryonic Antigen |
TPA |
Tissue Polypeptide Antigen |
TPS |
Tissue Polypeptide Specific Antigen |
CYFRA 21-1 |
cytokeratin-19 fragments |
HNSCC |
head and neck squamous cell cancer |
cf-DNA |
cell-free DNA |
ct-DNA |
cell-free tumoral DNA |
NPC |
nasopharyngeal carcinoma |
HPV ct-DNA |
circulating HPV DNA |
HPV16 ct-DNA |
circulating tumor HPV16 DNA |
AUC |
area under the curve |
dPCR |
digital PCR |
NGS |
next generation sequencing |
TIL |
tumor infiltrating lymphocyte therapy |
EBV |
Epstein-Barr Virus |
ASCC |
anal squamous cell carcinoma |
CNVs |
copy number variation |